Gerhard Ehninger - Concepedia

Author

Gerhard Ehninger

University Hospital Carl Gustav Carus ORCID

Also Known As

Christoph-Thomas Germer, Ehninger G, Ehninger, Gerhard, G E Ehninger, G Ehninger, G. EHNINGER, G. Ehninger, G. Ehninger, GERHARD EHNINGER, Gerhard Ehninger

1.2K

Publications

48.9K

Citations

104

H-Index

301

Concepts

All Affiliations

University Hospital Carl Gustav Carus Technische Universität Dresden Klinik und Poliklinik für Psychotherapie und Psychosomatik Heidelberg University Goethe University Frankfurt

About

Gerhard Ehninger is an author at University Hospital Carl Gustav Carus specializing in medicine, hematology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	59	235	14.2K
2	Health Sciences	34	63	4.3K
3	Engineering	12	12	495
4	Education	2	2	42
5	Management	1	1	33

Gerhard Ehninger

521

Publications

43.6K

Citations

101

H-Index

Page 1

	Year	Citations
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford, New England Journal of Medicine	2017	2.1K
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis Christian Thiede, Christine Steudel, Brigitte Mohr, Blood	2002	1.7K
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti, New England Journal of Medicine	2013	1.6K
Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro Joachim Oswald, Sabine Boxberger, Birgitte Jørgensen, Stem Cells	2004	1.3K
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors Claudio Anasetti, Brent R. Logan, Stephanie J. Lee, New England Journal of Medicine	2012	882
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML) Christian Thiede, Sina Koch, Eva Creutzig, Blood	2006	723
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN) Andreas Burchert, Gesine Bug, Lea Fritz, Journal of Clinical Oncology	2020	538
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party Christoph Schmid, Myriam Labopin, Arnon Nagler, Journal of Clinical Oncology	2007	513
Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3 Thomas Fischer, Richard M. Stone, Daniel J. DeAngelo, Journal of Clinical Oncology	2010	501
Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation H Einsele, Gerhard Ehninger, Holger Hebart, Blood	1995	453

Page 1